Shane Gleason
Corporate Officer/Principal chez INSPIREMD, INC.
Fortune : 985 009 $ au 30/04/2024
Profil
Shane Gleason is currently the Chief Commercial Officer at InspireMD, Inc. Prior to his current position, he held the role of Senior Director at Edwards Lifesciences Corp.
from 2019 to 2021.
From 2015 to 2017, he served as the Vice President-Sales at Cordis Corp.
In 2021 to 2023, he was the Vice President-Sales at Surmodics, Inc. He also served as the Chief Commercial Officer at Nuvaira, Inc. from 2017 to 2019.
Mr. Gleason obtained his undergraduate degree from Virginia Polytechnic Institute & State University and holds an MBA from The Stephen J.R.
Smith School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSPIREMD, INC.
2,20% | 18/04/2024 | 514 365 ( 2,20% ) | 985 009 $ | 30/04/2024 |
Postes actifs de Shane Gleason
| Sociétés | Poste | Début |
|---|---|---|
| INSPIREMD, INC. | Corporate Officer/Principal | 03/10/2023 |
Anciens postes connus de Shane Gleason
| Sociétés | Poste | Fin |
|---|---|---|
| SURMODICS, INC. | Sales & Marketing | 01/02/2023 |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | 01/06/2021 |
Nuvaira, Inc.
 Nuvaira, Inc. Electronic Equipment/InstrumentsElectronic Technology Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN. | Corporate Officer/Principal | 01/07/2019 |
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Sales & Marketing | 01/04/2017 |
Formation de Shane Gleason
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
| The Stephen J.R. Smith School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INSPIREMD, INC. | Health Technology |
| SURMODICS, INC. | Health Technology |
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Nuvaira, Inc.
Nuvaira, Inc. Electronic Equipment/InstrumentsElectronic Technology Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN. | Electronic Technology |
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
